Top news of the week: 14.07.2020.
#biospace #COVID19 #biotechnology #lifesciences #pharmaceuticals #vaccine #COVID #coronavirus #pandemic #cancer
Companies And Industries
US biotech @KymeraTx has begun a strategic collaboration with @sanofi to develop and market several drugs tackling immune-inflammatory disease, which could be worth up to $2 billion https://t.co/XMyw6VJt07 https://t.co/AtvRTRexKy
OpenKymera Therapeutics begins potential $2bn R&D deal with Sanofi
US biotech Kymera Therapeutics has begun a strategic collaboration with Sanofi to develop and market several drugs tackling immune-inflammatory disease, which could be worth up to $2 ...
Cardurion nabs Takeda plasma therapy R&D chief as new CMO https://t.co/g6sK3RP0xB https://t.co/X5czNLxpvz
OpenCardurion nabs Takeda plasma therapy R&D chief as new CMO
Since Takeda bought out Shire, it’s lost a number of high-ranking research execs from the Irish rare disease biotech, but today it’s also losing one from its own ranks.
Biopharma Update on the Novel Coronavirus: July 10
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #vaccine
https://t.co/Rf9kJHb5ay
OpenBiopharma Update on the Novel Coronavirus: July 10
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.
Biopharma Update on the Novel Coronavirus: July 8
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #vaccine
https://t.co/4qzxzZtahA
OpenBiopharma Update on the Novel Coronavirus: July 8
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 8, 2020.
China's Sinovac phase III trials in Brazil could take as little as three months https://t.co/olOlmZQ5Rn
OpenChina's Sinovac phase III trials in Brazil could take as little as three months
CAJICA, Colombia, and BEIJING – Last week Sinovac Biotech Ltd., of Beijing, announced the approval by Anvisa, the Brazilian health care surveillance agency, to start phase III trials to ...
Evive Biotech Sees Positive Results in Phase III Trial for CIN in Breast Cancer Patients
#biospace #lifesciences #biotechnology #pharmaceuticals #cancer
https://t.co/xzIqKueguw
OpenEvive Biotech Sees Positive Results in Phase III Trial for CIN in Breast Cancer Patients
Evive Biotech announced today that its Phase III study investigating F-627 to treat chemotherapy-induced neutropenia (CIN) in breast cancer patients has met its primary and secondary ...
Those tensions include resisting government experts’ advice on how to run the study and seeking a lower bar than proposed by the FDA to prove the vaccine works, as well as turning in trial protocols late https://t.co/X5v9hYlZHH
OpenModerna delay a snapshot of 'squabbles' with U.S. scientists over COVID-19 vaccine trials: Reuters
Late last week, Stat reported that Moderna would delay the phase 3 study of its COVID-19 vaccine, thanks to changes to the trial’s protocols. Such changes are not uncommon, highlighting ...
This month in GEN Magazine: Women scientists at the forefront of #COVID19 research, #CRISPR screening explores new dimensions, Bioprocessing 4.0, translational microbiomics... and more! https://t.co/bTJGq3kBsG https://t.co/vuryAPu79G
OpenJuly 2020 Vol. 40, No. 7
Read feature stories, columns, tutorials, and supplements. Discover new products and apps covering genetic engineering & biotechnology news.